BioCentury
ARTICLE | Clinical News

BMN 250: Phase I/II started

May 2, 2016 7:00 AM UTC

BioMarin began the open-label, dose-escalation, international Phase I/II BMN 250-201 trial to evaluate BMN 250 given via intracerebroventricular infusion. ...